nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—DRD1—attention deficit hyperactivity disorder	0.245	0.315	CbGaD
Perphenazine—ADRA2A—attention deficit hyperactivity disorder	0.227	0.292	CbGaD
Perphenazine—DRD2—attention deficit hyperactivity disorder	0.172	0.222	CbGaD
Perphenazine—HTR2A—attention deficit hyperactivity disorder	0.133	0.171	CbGaD
Perphenazine—HTR7—locus ceruleus—attention deficit hyperactivity disorder	0.00665	0.106	CbGeAlD
Perphenazine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00415	0.0659	CbGeAlD
Perphenazine—CALM1—autonomic nervous system—attention deficit hyperactivity disorder	0.00362	0.0574	CbGeAlD
Perphenazine—HTR7—autonomic nervous system—attention deficit hyperactivity disorder	0.00353	0.0561	CbGeAlD
Perphenazine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.0022	0.035	CbGeAlD
Perphenazine—HTR6—forebrain—attention deficit hyperactivity disorder	0.00177	0.0281	CbGeAlD
Perphenazine—DRD1—forebrain—attention deficit hyperactivity disorder	0.00132	0.0209	CbGeAlD
Perphenazine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00102	0.0163	CbGeAlD
Perphenazine—HTR6—nervous system—attention deficit hyperactivity disorder	0.000962	0.0153	CbGeAlD
Perphenazine—HTR6—central nervous system—attention deficit hyperactivity disorder	0.000926	0.0147	CbGeAlD
Perphenazine—DRD1—midbrain—attention deficit hyperactivity disorder	0.00087	0.0138	CbGeAlD
Perphenazine—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000862	0.0137	CbGeAlD
Perphenazine—CALM2—forebrain—attention deficit hyperactivity disorder	0.000847	0.0134	CbGeAlD
Perphenazine—CALM1—forebrain—attention deficit hyperactivity disorder	0.000843	0.0134	CbGeAlD
Perphenazine—HTR7—forebrain—attention deficit hyperactivity disorder	0.000824	0.0131	CbGeAlD
Perphenazine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000779	0.0124	CbGeAlD
Perphenazine—HTR6—brain—attention deficit hyperactivity disorder	0.000735	0.0117	CbGeAlD
Perphenazine—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000729	0.0116	CbGeAlD
Perphenazine—CALM2—cardiovascular system—attention deficit hyperactivity disorder	0.000716	0.0114	CbGeAlD
Perphenazine—DRD1—nervous system—attention deficit hyperactivity disorder	0.000716	0.0114	CbGeAlD
Perphenazine—CALM1—cardiovascular system—attention deficit hyperactivity disorder	0.000713	0.0113	CbGeAlD
Perphenazine—CALM3—midbrain—attention deficit hyperactivity disorder	0.000712	0.0113	CbGeAlD
Perphenazine—HTR7—cardiovascular system—attention deficit hyperactivity disorder	0.000696	0.0111	CbGeAlD
Perphenazine—DRD1—central nervous system—attention deficit hyperactivity disorder	0.000689	0.0109	CbGeAlD
Perphenazine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000676	0.0107	CbGeAlD
Perphenazine—HRH1—forebrain—attention deficit hyperactivity disorder	0.000615	0.00976	CbGeAlD
Perphenazine—AOX1—cerebellum—attention deficit hyperactivity disorder	0.000612	0.00971	CbGeAlD
Perphenazine—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000604	0.00959	CbGeAlD
Perphenazine—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000569	0.00904	CbGeAlD
Perphenazine—CALM2—midbrain—attention deficit hyperactivity disorder	0.000559	0.00888	CbGeAlD
Perphenazine—CALM1—midbrain—attention deficit hyperactivity disorder	0.000557	0.00884	CbGeAlD
Perphenazine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000556	0.00883	CbGeAlD
Perphenazine—CALM3—cerebellum—attention deficit hyperactivity disorder	0.000551	0.00875	CbGeAlD
Perphenazine—DRD1—brain—attention deficit hyperactivity disorder	0.000547	0.00868	CbGeAlD
Perphenazine—HTR7—midbrain—attention deficit hyperactivity disorder	0.000544	0.00864	CbGeAlD
Perphenazine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000535	0.0085	CbGeAlD
Perphenazine—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000532	0.00845	CbGeAlD
Perphenazine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000527	0.00837	CbGeAlD
Perphenazine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000514	0.00816	CbGeAlD
Perphenazine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000514	0.00815	CbGeAlD
Perphenazine—AOX1—brain—attention deficit hyperactivity disorder	0.000497	0.00789	CbGeAlD
Perphenazine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000468	0.00743	CbGeAlD
Perphenazine—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000468	0.00743	CbGeAlD
Perphenazine—CALM2—nervous system—attention deficit hyperactivity disorder	0.00046	0.0073	CbGeAlD
Perphenazine—CALM1—nervous system—attention deficit hyperactivity disorder	0.000458	0.00727	CbGeAlD
Perphenazine—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.00045	0.00715	CbGeAlD
Perphenazine—CALM3—brain—attention deficit hyperactivity disorder	0.000448	0.00711	CbGeAlD
Perphenazine—HTR7—nervous system—attention deficit hyperactivity disorder	0.000447	0.0071	CbGeAlD
Perphenazine—CALM2—central nervous system—attention deficit hyperactivity disorder	0.000443	0.00703	CbGeAlD
Perphenazine—CALM1—central nervous system—attention deficit hyperactivity disorder	0.000441	0.007	CbGeAlD
Perphenazine—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.00044	0.00699	CbGeAlD
Perphenazine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000434	0.0069	CbGeAlD
Perphenazine—CALM2—cerebellum—attention deficit hyperactivity disorder	0.000433	0.00687	CbGeAlD
Perphenazine—CALM1—cerebellum—attention deficit hyperactivity disorder	0.000431	0.00684	CbGeAlD
Perphenazine—HTR7—central nervous system—attention deficit hyperactivity disorder	0.00043	0.00683	CbGeAlD
Perphenazine—HTR2C—brain—attention deficit hyperactivity disorder	0.000425	0.00675	CbGeAlD
Perphenazine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000423	0.00671	CbGeAlD
Perphenazine—HTR7—cerebellum—attention deficit hyperactivity disorder	0.000421	0.00668	CbGeAlD
Perphenazine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000407	0.00646	CbGeAlD
Perphenazine—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000399	0.00633	CbGeAlD
Perphenazine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000398	0.00632	CbGeAlD
Perphenazine—HTR1A—brain—attention deficit hyperactivity disorder	0.000358	0.00568	CbGeAlD
Perphenazine—CALM2—brain—attention deficit hyperactivity disorder	0.000351	0.00558	CbGeAlD
Perphenazine—CALM1—brain—attention deficit hyperactivity disorder	0.00035	0.00555	CbGeAlD
Perphenazine—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000342	0.00543	CbGeAlD
Perphenazine—HTR7—brain—attention deficit hyperactivity disorder	0.000342	0.00543	CbGeAlD
Perphenazine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000339	0.00538	CbGeAlD
Perphenazine—HRH1—nervous system—attention deficit hyperactivity disorder	0.000334	0.0053	CbGeAlD
Perphenazine—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000329	0.00523	CbGeAlD
Perphenazine—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000328	0.00521	CbGeAlD
Perphenazine—DRD2—brain—attention deficit hyperactivity disorder	0.000323	0.00513	CbGeAlD
Perphenazine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000321	0.0051	CbGeAlD
Perphenazine—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000316	0.00501	CbGeAlD
Perphenazine—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000309	0.0049	CbGeAlD
Perphenazine—CYP2C8—brain—attention deficit hyperactivity disorder	0.000291	0.00462	CbGeAlD
Perphenazine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000279	0.00443	CbGeAlD
Perphenazine—Zuclopenthixol—DRD5—attention deficit hyperactivity disorder	0.000277	0.0295	CrCbGaD
Perphenazine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000268	0.00426	CbGeAlD
Perphenazine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000262	0.00417	CbGeAlD
Perphenazine—CYP2B6—brain—attention deficit hyperactivity disorder	0.000261	0.00415	CbGeAlD
Perphenazine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000258	0.0041	CbGeAlD
Perphenazine—Aripiprazole—DRD5—attention deficit hyperactivity disorder	0.000256	0.0273	CrCbGaD
Perphenazine—HRH1—brain—attention deficit hyperactivity disorder	0.000255	0.00405	CbGeAlD
Perphenazine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000254	0.00403	CbGeAlD
Perphenazine—ADRA2A—brain—attention deficit hyperactivity disorder	0.000251	0.00398	CbGeAlD
Perphenazine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000249	0.00395	CbGeAlD
Perphenazine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000245	0.00388	CbGeAlD
Perphenazine—Aripiprazole—ADRA2C—attention deficit hyperactivity disorder	0.000241	0.0257	CrCbGaD
Perphenazine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000239	0.0038	CbGeAlD
Perphenazine—HTR2A—brain—attention deficit hyperactivity disorder	0.000213	0.00338	CbGeAlD
Perphenazine—Flupentixol—DRD1—attention deficit hyperactivity disorder	0.000213	0.0227	CrCbGaD
Perphenazine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000194	0.00308	CbGeAlD
Perphenazine—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.000189	0.0202	CrCbGaD
Perphenazine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.000169	0.0181	CrCbGaD
Perphenazine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.000167	0.0178	CrCbGaD
Perphenazine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.00016	0.017	CrCbGaD
Perphenazine—Quetiapine—DRD5—attention deficit hyperactivity disorder	0.00016	0.017	CrCbGaD
Perphenazine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.000155	0.0166	CrCbGaD
Perphenazine—Quetiapine—ADRA2C—attention deficit hyperactivity disorder	0.000151	0.0161	CrCbGaD
Perphenazine—Flupentixol—DRD2—attention deficit hyperactivity disorder	0.00015	0.016	CrCbGaD
Perphenazine—Domperidone—DRD3—attention deficit hyperactivity disorder	0.000146	0.0156	CrCbGaD
Perphenazine—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.000133	0.0142	CrCbGaD
Perphenazine—Aripiprazole—DRD4—attention deficit hyperactivity disorder	0.000131	0.0139	CrCbGaD
Perphenazine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.000129	0.0138	CrCbGaD
Perphenazine—Zuclopenthixol—DRD1—attention deficit hyperactivity disorder	0.00012	0.0128	CrCbGaD
Perphenazine—Aripiprazole—HTR1B—attention deficit hyperactivity disorder	0.000116	0.0124	CrCbGaD
Perphenazine—Flupentixol—HTR2A—attention deficit hyperactivity disorder	0.000116	0.0124	CrCbGaD
Perphenazine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.000116	0.0124	CrCbGaD
Perphenazine—Nefazodone—SLC6A3—attention deficit hyperactivity disorder	0.000113	0.012	CrCbGaD
Perphenazine—Aripiprazole—DRD3—attention deficit hyperactivity disorder	0.000113	0.012	CrCbGaD
Perphenazine—Zuclopenthixol—ADRA2A—attention deficit hyperactivity disorder	0.000111	0.0119	CrCbGaD
Perphenazine—Aripiprazole—DRD1—attention deficit hyperactivity disorder	0.000111	0.0118	CrCbGaD
Perphenazine—Nefazodone—ADRA2A—attention deficit hyperactivity disorder	0.000111	0.0118	CrCbGaD
Perphenazine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.000107	0.0114	CrCbGaD
Perphenazine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.000105	0.0112	CrCbGaD
Perphenazine—Mesoridazine—DRD3—attention deficit hyperactivity disorder	0.000104	0.0111	CrCbGaD
Perphenazine—Thiothixene—DRD1—attention deficit hyperactivity disorder	0.000103	0.011	CrCbGaD
Perphenazine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	0.000103	0.011	CrCbGaD
Perphenazine—Aripiprazole—ADRA2A—attention deficit hyperactivity disorder	0.000103	0.011	CrCbGaD
Perphenazine—Trazodone—ADRA2A—attention deficit hyperactivity disorder	0.000102	0.0109	CrCbGaD
Perphenazine—Propiomazine—DRD4—attention deficit hyperactivity disorder	0.000101	0.0108	CrCbGaD
Perphenazine—Domperidone—DRD2—attention deficit hyperactivity disorder	0.000101	0.0108	CrCbGaD
Perphenazine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.0001	0.0107	CrCbGaD
Perphenazine—Thiothixene—ADRA2A—attention deficit hyperactivity disorder	9.59e-05	0.0102	CrCbGaD
Perphenazine—Cyamemazine—HTR2A—attention deficit hyperactivity disorder	9.1e-05	0.0097	CrCbGaD
Perphenazine—Fluphenazine—DRD3—attention deficit hyperactivity disorder	9.09e-05	0.00969	CrCbGaD
Perphenazine—Fluphenazine—DRD1—attention deficit hyperactivity disorder	8.92e-05	0.00951	CrCbGaD
Perphenazine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	8.67e-05	0.00924	CrCbGaD
Perphenazine—Propiomazine—DRD1—attention deficit hyperactivity disorder	8.58e-05	0.00915	CrCbGaD
Perphenazine—Zuclopenthixol—DRD2—attention deficit hyperactivity disorder	8.44e-05	0.009	CrCbGaD
Perphenazine—Nefazodone—SLC6A4—attention deficit hyperactivity disorder	8.44e-05	0.009	CrCbGaD
Perphenazine—Fluphenazine—ADRA2A—attention deficit hyperactivity disorder	8.29e-05	0.00884	CrCbGaD
Perphenazine—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	8.28e-05	0.00882	CrCbGaD
Perphenazine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	8.18e-05	0.00872	CrCbGaD
Perphenazine—Quetiapine—DRD4—attention deficit hyperactivity disorder	8.17e-05	0.00871	CrCbGaD
Perphenazine—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	8.12e-05	0.00866	CrCbGaD
Perphenazine—Aripiprazole—SLC6A4—attention deficit hyperactivity disorder	7.85e-05	0.00836	CrCbGaD
Perphenazine—Trazodone—SLC6A4—attention deficit hyperactivity disorder	7.81e-05	0.00833	CrCbGaD
Perphenazine—Aripiprazole—DRD2—attention deficit hyperactivity disorder	7.8e-05	0.00832	CrCbGaD
Perphenazine—Thioridazine—DRD1—attention deficit hyperactivity disorder	7.69e-05	0.00819	CrCbGaD
Perphenazine—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	7.58e-05	0.00808	CrCbGaD
Perphenazine—Acepromazine—DRD2—attention deficit hyperactivity disorder	7.57e-05	0.00807	CrCbGaD
Perphenazine—Promazine—DRD4—attention deficit hyperactivity disorder	7.51e-05	0.00801	CrCbGaD
Perphenazine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	7.48e-05	0.00797	CrCbGaD
Perphenazine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	7.4e-05	0.00789	CrCbGaD
Perphenazine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	7.34e-05	0.00782	CrCbGaD
Perphenazine—Thiothixene—DRD2—attention deficit hyperactivity disorder	7.28e-05	0.00776	CrCbGaD
Perphenazine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	7.28e-05	0.00776	CrCbGaD
Perphenazine—Quetiapine—HTR1B—attention deficit hyperactivity disorder	7.26e-05	0.00774	CrCbGaD
Perphenazine—Mesoridazine—DRD2—attention deficit hyperactivity disorder	7.18e-05	0.00766	CrCbGaD
Perphenazine—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	7.14e-05	0.00761	CrCbGaD
Perphenazine—Quetiapine—DRD3—attention deficit hyperactivity disorder	7.05e-05	0.00751	CrCbGaD
Perphenazine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	6.95e-05	0.00741	CrCbGaD
Perphenazine—Quetiapine—DRD1—attention deficit hyperactivity disorder	6.92e-05	0.00737	CrCbGaD
Perphenazine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	6.82e-05	0.00727	CrCbGaD
Perphenazine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	6.61e-05	0.00705	CrCbGaD
Perphenazine—Zuclopenthixol—HTR2A—attention deficit hyperactivity disorder	6.52e-05	0.00695	CrCbGaD
Perphenazine—Nefazodone—HTR2A—attention deficit hyperactivity disorder	6.49e-05	0.00691	CrCbGaD
Perphenazine—Quetiapine—ADRA2A—attention deficit hyperactivity disorder	6.43e-05	0.00685	CrCbGaD
Perphenazine—Promazine—DRD1—attention deficit hyperactivity disorder	6.36e-05	0.00678	CrCbGaD
Perphenazine—Fluphenazine—DRD2—attention deficit hyperactivity disorder	6.29e-05	0.00671	CrCbGaD
Perphenazine—Propiomazine—DRD2—attention deficit hyperactivity disorder	6.05e-05	0.00645	CrCbGaD
Perphenazine—Aripiprazole—HTR2A—attention deficit hyperactivity disorder	6.03e-05	0.00643	CrCbGaD
Perphenazine—Trazodone—HTR2A—attention deficit hyperactivity disorder	6e-05	0.0064	CrCbGaD
Perphenazine—Promazine—ADRA2A—attention deficit hyperactivity disorder	5.91e-05	0.0063	CrCbGaD
Perphenazine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	5.85e-05	0.00623	CrCbGaD
Perphenazine—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	5.78e-05	0.00617	CrCbGaD
Perphenazine—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	5.73e-05	0.00611	CrCbGaD
Perphenazine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	5.72e-05	0.00609	CrCbGaD
Perphenazine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	5.7e-05	0.00608	CrCbGaD
Perphenazine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	5.62e-05	0.006	CrCbGaD
Perphenazine—Thiothixene—HTR2A—attention deficit hyperactivity disorder	5.62e-05	0.006	CrCbGaD
Perphenazine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	5.6e-05	0.00597	CrCbGaD
Perphenazine—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	5.55e-05	0.00592	CrCbGaD
Perphenazine—Thioridazine—DRD2—attention deficit hyperactivity disorder	5.42e-05	0.00578	CrCbGaD
Perphenazine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	5.2e-05	0.00554	CrCbGaD
Perphenazine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	5.17e-05	0.00552	CrCbGaD
Perphenazine—Promethazine—DRD2—attention deficit hyperactivity disorder	5.1e-05	0.00543	CrCbGaD
Perphenazine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	5.03e-05	0.00536	CrCbGaD
Perphenazine—Quetiapine—DRD2—attention deficit hyperactivity disorder	4.88e-05	0.0052	CrCbGaD
Perphenazine—Fluphenazine—HTR2A—attention deficit hyperactivity disorder	4.86e-05	0.00518	CrCbGaD
Perphenazine—Propiomazine—HTR2A—attention deficit hyperactivity disorder	4.68e-05	0.00498	CrCbGaD
Perphenazine—Promazine—DRD2—attention deficit hyperactivity disorder	4.48e-05	0.00478	CrCbGaD
Perphenazine—Clomipramine—HTR2A—attention deficit hyperactivity disorder	4.45e-05	0.00474	CrCbGaD
Perphenazine—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	4.43e-05	0.00472	CrCbGaD
Perphenazine—Thioridazine—HTR2A—attention deficit hyperactivity disorder	4.19e-05	0.00446	CrCbGaD
Perphenazine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	4e-05	0.00426	CrCbGaD
Perphenazine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	3.95e-05	0.00421	CrCbGaD
Perphenazine—Promethazine—HTR2A—attention deficit hyperactivity disorder	3.94e-05	0.0042	CrCbGaD
Perphenazine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	3.89e-05	0.00414	CrCbGaD
Perphenazine—Quetiapine—HTR2A—attention deficit hyperactivity disorder	3.77e-05	0.00402	CrCbGaD
Perphenazine—Promazine—HTR2A—attention deficit hyperactivity disorder	3.46e-05	0.00369	CrCbGaD
Perphenazine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	3.05e-05	0.00325	CrCbGaD
Perphenazine—CALM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.66e-05	0.000111	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.66e-05	0.000111	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.66e-05	0.000111	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.66e-05	0.000111	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.63e-05	0.000109	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.63e-05	0.000108	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.62e-05	0.000108	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	1.62e-05	0.000108	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.62e-05	0.000108	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.62e-05	0.000108	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.62e-05	0.000108	CbGpPWpGaD
Perphenazine—CALM1—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	1.62e-05	0.000108	CbGpPWpGaD
Perphenazine—CALM2—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	1.62e-05	0.000108	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.61e-05	0.000107	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	1.59e-05	0.000106	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.59e-05	0.000106	CbGpPWpGaD
Perphenazine—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.58e-05	0.000105	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.57e-05	0.000105	CbGpPWpGaD
Perphenazine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.57e-05	0.000104	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.57e-05	0.000104	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.57e-05	0.000104	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.55e-05	0.000103	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.54e-05	0.000103	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.54e-05	0.000103	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.53e-05	0.000102	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.53e-05	0.000102	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.52e-05	0.000101	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.52e-05	0.000101	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.52e-05	0.000101	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.52e-05	0.000101	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.52e-05	0.000101	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.51e-05	0.0001	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.49e-05	9.95e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.49e-05	9.92e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.48e-05	9.87e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.48e-05	9.87e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—TPH2—attention deficit hyperactivity disorder	1.48e-05	9.85e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.48e-05	9.85e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.47e-05	9.82e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.47e-05	9.76e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.46e-05	9.76e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.46e-05	9.74e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—DPYD—attention deficit hyperactivity disorder	1.45e-05	9.69e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.43e-05	9.53e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.43e-05	9.53e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.43e-05	9.53e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.43e-05	9.53e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.43e-05	9.53e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.42e-05	9.48e-05	CbGpPWpGaD
Perphenazine—AOX1—Disease—EP300—attention deficit hyperactivity disorder	1.42e-05	9.45e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.42e-05	9.44e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.42e-05	9.44e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—SNAP25—attention deficit hyperactivity disorder	1.41e-05	9.4e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.41e-05	9.37e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.41e-05	9.37e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.4e-05	9.35e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.39e-05	9.25e-05	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.38e-05	9.22e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.38e-05	9.18e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	1.38e-05	9.17e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.37e-05	9.13e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—SNAP25—attention deficit hyperactivity disorder	1.37e-05	9.09e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—SNAP25—attention deficit hyperactivity disorder	1.37e-05	9.09e-05	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.36e-05	9.05e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.35e-05	9.01e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.33e-05	8.89e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.33e-05	8.88e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	1.33e-05	8.87e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	1.33e-05	8.87e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.33e-05	8.84e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.31e-05	8.74e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.31e-05	8.71e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.31e-05	8.71e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.3e-05	8.69e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.3e-05	8.67e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.3e-05	8.63e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.3e-05	8.63e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.3e-05	8.63e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.29e-05	8.59e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	1.29e-05	8.57e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.29e-05	8.57e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.28e-05	8.53e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.28e-05	8.51e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	1.27e-05	8.43e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.26e-05	8.37e-05	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.24e-05	8.25e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.23e-05	8.22e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.22e-05	8.1e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.21e-05	8.09e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.21e-05	8.06e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.21e-05	8.04e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.2e-05	8e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.19e-05	7.93e-05	CbGpPWpGaD
Perphenazine—AOX1—Metabolism—EP300—attention deficit hyperactivity disorder	1.19e-05	7.92e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.19e-05	7.91e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.18e-05	7.87e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.18e-05	7.84e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.18e-05	7.84e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.18e-05	7.84e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.17e-05	7.81e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.16e-05	7.76e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.16e-05	7.7e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.15e-05	7.68e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.15e-05	7.67e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.15e-05	7.66e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	1.15e-05	7.65e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.15e-05	7.65e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.14e-05	7.62e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.14e-05	7.62e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.14e-05	7.61e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.14e-05	7.6e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.14e-05	7.58e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.13e-05	7.55e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.13e-05	7.53e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	1.13e-05	7.52e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.12e-05	7.49e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.12e-05	7.49e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.12e-05	7.46e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.12e-05	7.44e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.09e-05	7.25e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.09e-05	7.25e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.08e-05	7.21e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.06e-05	7.08e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.06e-05	7.03e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.06e-05	7.03e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.05e-05	6.99e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.05e-05	6.99e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	1.05e-05	6.97e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.05e-05	6.97e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.04e-05	6.95e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.04e-05	6.93e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.04e-05	6.92e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	1.04e-05	6.92e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	1.03e-05	6.86e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.03e-05	6.85e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.03e-05	6.85e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.03e-05	6.85e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.03e-05	6.84e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.02e-05	6.78e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1e-05	6.66e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.93e-06	6.61e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.93e-06	6.61e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.88e-06	6.58e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.83e-06	6.55e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	9.82e-06	6.54e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.79e-06	6.52e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	9.75e-06	6.49e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.66e-06	6.43e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.57e-06	6.38e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.57e-06	6.38e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.56e-06	6.37e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.56e-06	6.37e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.49e-06	6.32e-05	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—EP300—attention deficit hyperactivity disorder	9.47e-06	6.31e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.41e-06	6.27e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.29e-06	6.19e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.26e-06	6.17e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.26e-06	6.17e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	9.2e-06	6.13e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.18e-06	6.11e-05	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—EP300—attention deficit hyperactivity disorder	9.16e-06	6.1e-05	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—EP300—attention deficit hyperactivity disorder	9.16e-06	6.1e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	9.14e-06	6.09e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.1e-06	6.06e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.1e-06	6.06e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.99e-06	5.99e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.99e-06	5.99e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—COMT—attention deficit hyperactivity disorder	8.96e-06	5.97e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	8.94e-06	5.96e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.94e-06	5.96e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—MAOA—attention deficit hyperactivity disorder	8.89e-06	5.92e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	8.8e-06	5.86e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.74e-06	5.82e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—COMT—attention deficit hyperactivity disorder	8.66e-06	5.77e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—COMT—attention deficit hyperactivity disorder	8.66e-06	5.77e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.65e-06	5.77e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—MAOA—attention deficit hyperactivity disorder	8.6e-06	5.73e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.6e-06	5.73e-05	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—EP300—attention deficit hyperactivity disorder	8.53e-06	5.68e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.45e-06	5.63e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.44e-06	5.62e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.41e-06	5.6e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.37e-06	5.58e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.37e-06	5.58e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.37e-06	5.57e-05	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—EP300—attention deficit hyperactivity disorder	8.25e-06	5.5e-05	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—EP300—attention deficit hyperactivity disorder	8.25e-06	5.5e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.18e-06	5.45e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.03e-06	5.35e-05	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—EP300—attention deficit hyperactivity disorder	8.03e-06	5.35e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.96e-06	5.31e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	7.79e-06	5.19e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	7.74e-06	5.15e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.5e-06	5e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.42e-06	4.94e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.29e-06	4.85e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.15e-06	4.76e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	6.95e-06	4.63e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	6.9e-06	4.6e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.9e-06	4.6e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	6.9e-06	4.6e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.81e-06	4.53e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	6.79e-06	4.52e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.7e-06	4.46e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.64e-06	4.43e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	6.4e-06	4.26e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	6.35e-06	4.23e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	6.34e-06	4.22e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.31e-06	4.21e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	6.3e-06	4.19e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.11e-06	4.07e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.06e-06	4.04e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.05e-06	4.03e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.04e-06	4.03e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.86e-06	3.91e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.86e-06	3.91e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.52e-06	3.68e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	5.42e-06	3.61e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	5.38e-06	3.58e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.25e-06	3.5e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.22e-06	3.48e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.21e-06	3.47e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—EP300—attention deficit hyperactivity disorder	4.97e-06	3.31e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—EP300—attention deficit hyperactivity disorder	4.8e-06	3.2e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—EP300—attention deficit hyperactivity disorder	4.8e-06	3.2e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—EP300—attention deficit hyperactivity disorder	4.59e-06	3.06e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.48e-06	2.98e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.46e-06	2.97e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EP300—attention deficit hyperactivity disorder	4.44e-06	2.96e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EP300—attention deficit hyperactivity disorder	4.44e-06	2.96e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	4.21e-06	2.8e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.18e-06	2.79e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.15e-06	2.77e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	3.95e-06	2.63e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.93e-06	2.62e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.87e-06	2.58e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.86e-06	2.57e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—EP300—attention deficit hyperactivity disorder	3.84e-06	2.56e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—EP300—attention deficit hyperactivity disorder	3.72e-06	2.48e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—EP300—attention deficit hyperactivity disorder	3.72e-06	2.48e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.52e-06	2.34e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	3.34e-06	2.23e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.21e-06	2.14e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.11e-06	2.07e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.11e-06	2.07e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	2.98e-06	1.99e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2.74e-06	1.83e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.72e-06	1.81e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	2.32e-06	1.55e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.79e-06	1.19e-05	CbGpPWpGaD
